Exploration of the optimal treatment regimes for Esthesioneuroblastoma: a single center experience in China.

Exploration of the optimal treatment regimes for Esthesioneuroblastoma: a single center experience in China.
复制标题

感受神经母细胞瘤最佳治疗方案的探索:中国单中心经验

DOI:
10.7150/jca.21605
复制
发表时间:
2018
期刊:
影响因子:
3.9
通讯作者:
Ren Y
Ren Y
中科院分区:
医学3区
文献类型:
--
作者:
Yuan Y;Ye J;Qiu H;Niu S;Wen B;Wang D;Cao X;Ren Y

文献摘要

参考文献

被引文献

相似文献

BACKGROUND: Esthesioneuroblastoma (ENB) is an uncommon neoplasm arising from the olfactory mucosa. The optimal treatment regimen for ENB remains unclear. This study aims to evaluate its clinical features, long-term outcomes and explore optimal treatment patterns. METHODS: Clinical data of consecutive 44 ENB patients were reviewed retrospectively. The correlation between clinical features and treatment approaches were analyzed, with several prognostic factors explored meanwhile. RESULTS: The age of onset of ENB showed a bimodal distribution, with peaks at 10~20 and 50~60 years. The median follow-up time was 84 months (range, 27~198 months).The 5-year overall and progression free survival rates were 42.7% and 39.1%, respectively, with 10-year rates of 28.9% and 21.7% respectively. Overall, 19 patients developed recurrent disease. Patients undergoing surgery combined with adjuvant radiotherapy had significantly higher 5-year overall survival (67.5% vs. 33.3%, P=0.043) and progress-free survival (60.0%vs. 18.7%, P=0.008) than those receiving other treatment approaches. No-Skin-involved ENB was associated with markedly better 5-year overall survival (45.5%vs.0 %, P=0.038) and progress-free survival (31.3% vs. 0 %, P=0.001) compared with skin-involved tumor. CONCLUSIONS: ENB is a rarely malignant tumor with high probability of locoregional recurrence and poor survival. Surgical resection followed by radiotherapy has been shown to achieve optimal local control and overall survival.
DOI: 10.1097/coc.0b013e31829b5631
发表时间: 2015-06-01
影响因子: 2.6
作者:
Hollen, Tyler R.;Morris, Christopher G.;Mendenhall, William M.
通讯作者: Mendenhall, William M.
DOI: 10.1016/j.anl.2014.10.003
发表时间: 2015-04-01
期刊: AURIS NASUS LARYNX
影响因子: 1.7
作者:
Matsunaga, Mami;Nakagawa, Takayuki;Ito, Juichi
通讯作者: Ito, Juichi
DOI: 10.1016/s0360-3016(02)02941-3
发表时间: 2002-10-01
影响因子: 7
作者:
Gruber, GN;Laedrach, K;Greiner, R
通讯作者: Greiner, R
DOI: 10.1002/hed.10247
发表时间: 2003-07-01
影响因子: 2.9
作者:
Monroe, AT;Hinerman, RW;Mendenhall, WM
通讯作者: Mendenhall, WM
DOI: 10.4081/rt.2011.e1
发表时间: 2011-03-30
期刊: Rare tumors
影响因子: 0.9
作者:
Aljumaily RM;Nystrom JS;Wein RO
通讯作者: Wein RO